Melissa Irvin Sahm
Adult Health · Owings Mills, MDNPI 1356978530
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 306 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by Novo Nordisk at 24.4% of the total. Among adult health clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 306 payments — averaging $16.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$558
- Pfizer$549
- Lilly USA, LLC$528
- AstraZeneca$274
- Bayer$223
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,170100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 88 | $1,261 |
| AbbVie | 34 | $558 |
| Pfizer | 32 | $549 |
| Lilly USA, LLC | 37 | $528 |
| AstraZeneca | 14 | $274 |
| Bayer | 10 | $223 |
| Boehringer Ingelheim | 12 | $186 |
| GSK | 8 | $161 |
| Exact Sciences | 6 | $144 |
| Nevro Corp. | 6 | $116 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $114 |
| Astellas Pharma US Inc | 5 | $108 |
| Amgen(2 entities) | 5 | $102 |
| Novavax Inc | 3 | $76 |
| Idorsia Pharmaceuticals US Inc | 4 | $71 |
| Amarin Pharma, Inc. | 3 | $67 |
| Biohaven Pharmaceuticals, Inc. | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Novartis | 3 | $55 |
| Medtronic | 3 | $52 |
| Sumitomo Pharma America, Inc. | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Gilead | 2 | $47 |
| Lundbeck LLC | 2 | $32 |
| Currax Pharmaceuticals LLC | 2 | $31 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Johnson & Johnson | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Merck | 1 | $27 |
| Phadia US Inc. | 1 | $21 |
| Cequr Corporation | 1 | $16 |
| Seqirus USA Inc | 1 | $15 |
| Resmed Corp | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
How this compares
$5,170 in reported general payments places this provider in the 90th percentile of 542 adult health providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 14 | $14,278 |
| Atorvastatin Calcium | 134 | $1,673 |
| Losartan Potassium | 51 | $1,049 |
| Rosuvastatin Calcium | 40 | $940 |
| Famotidine | 32 | $722 |
| Metoprolol Succinate | 41 | $679 |
| Montelukast Sodium | 20 | $499 |
| Amlodipine Besylate | 55 | $457 |
| Omeprazole | 29 | $427 |
| Escitalopram Oxalate | 22 | $381 |
| Levothyroxine Sodium | 40 | $370 |
| Gabapentin | 22 | $331 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $272 |
| Atenolol | 13 | $249 |
| Pantoprazole Sodium | 16 | $234 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,261 | $14,27814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 542 adult health providers in Maryland.
Other adult health in Owings Mills
- Camelle ReddingOwings Mills$5K
- Lucia NovakCamp Springs$473K
- Caroline RuhlAnnapolis$315K
- Joyce MiskovicHighland$264K
- Christopher RobersonBaltimore$180K
- Amit DhirBaltimore$97K
- Morgan JoliatSykesville$92K
- Brendon BowerBaltimore$64K
- Caitlin NassBaltimore$46K
- Jane KapustinClarksville$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.